The Handbook of Medicinal Chemistry: Principles and Practice, Hardcover/Andrew Davis

Descriere YEO:

The Handbook of Medicinal Chemistry: - Disponibil la elefant.ro

Pe YEO găsești The Handbook of Medicinal Chemistry: de la Royal Society of Chemistry, în categoria Foreign Books.

Indiferent de nevoile tale, The Handbook of Medicinal Chemistry: Principles and Practice, Hardcover/Andrew Davis din categoria Foreign Books îți poate aduce un echilibru perfect între calitate și preț, cu avantaje practice și moderne.

Preț: 729.99 Lei

Caracteristicile produsului The Handbook of Medicinal Chemistry:

• Brand: Royal Society of Chemistry
• Categoria: Foreign Books
• Magazin: elefant.ro
• Ultima actualizare: 03-05-2025 02:21:46

Comandă The Handbook of Medicinal Chemistry: Online, Simplu și Rapid

Prin intermediul platformei YEO, poți comanda The Handbook of Medicinal Chemistry: de la elefant.ro rapid și în siguranță. Bucură-te de o experiență de cumpărături online optimizată și descoperă cele mai bune oferte actualizate constant.

Descriere magazin:
Description Drug discovery is a constantly developing and expanding area of research. Developed to provide a comprehensive guide, the Handbook of Medicinal Chemistry covers the past, present and future of the entire drug development process. Highlighting the recent successes and failures, the book will help readers to understand the factors governing modern drug discovery from the initial concept through to translational science and intellectual property. Each chapter includes expert advice to not only provide a rigorous understanding of the principles being discussed, but to provide useful hints and tips gained from within the pharmaceutical industry to enable medicinal chemists to fully understand the entire drug discovery process and every area in which medicinal chemists are critically involved. This expert advice, combined with project case studies, highlighting and discussing all areas of successful projects, make this an essential handbook for all those involved in pharmaceutical development. About the Author Andrew Davis read Chemistry at Imperial College of Science and Technology and then completed a PhD in Physical Organic Chemistry with Professor MI Page at the University of Huddersfield. He joined Fisons PLC Pharmaceuticals Division in 1988, which became part of the Swedish pharmaceutical company Astra AB in 1995. Astra merged with Zeneca PLC in 1999 to form AstraZeneca PLC. Dr Davis has spent the last 23 years in drug discovery, in line management, project and portfolio management and senior science roles. He has recently relocated to Sweden with AstraZeneca as Senior Principal Scientist and project leader in Chemistry with the Respiratory and Inflammation Innovative Medicines in Gothenburg. Simon Ward has an MA in Natural Sciences and a PhD in synthetic organic chemistry from Cambridge University. He has a wide ranging experience of drug discovery in both large and small companies (GlaxoSmithKline, Knoll Pharmaceuticals, Vernalis, Chiroscience) and specialist experience of discovering and developing drugs for central nervous system indications. He has led multidisciplinary project teams and medicinal chemistry groups from target identification, through to early clinical studies, delivering multiple clinical development candidates across indications. Simon is a Fellow of the Royal Society of Chemistry and is currently Professor of Medicinal Chemistry at the University of Sussex, UK and Director of the Translational Drug Discovery Group, which he established within the University of Sussex in 2010.